# | ||||
---|---|---|---|---|
1 | DSBREPAIR Developmental and Genetic Analysis of DNA Double-Strand Break Repair | 2008 | 1˙060˙000.00 | 1˙060˙000.00 |
2 | TALOS Targeting LRP5 to Increase Bone Formation in Osteoporosis | 2008 | 3˙898˙406.00 | 2˙904˙304.00 |
3 | MASTERSWITCH Mechanisms to Attack Steering Effectors of Rheumatoid Syndromes with Innovated Therapy Choices | 2008 | 14˙805˙808.00 | 11˙235˙980.00 |
4 | PHASE A PHArmacogenomic study of Statins in the Elderly at risk for cardiovascular disease | 2009 | 3˙766˙919.00 | 2˙858˙188.00 |
5 | THESCHISTOVAC The targeted development of a new generation Vaccine for Schistosomiasis | 2010 | 5˙161˙126.00 | 3˙799˙975.00 |
6 | CD40RA Identification of functional common and rare variants in the CD40 signaling pathway in Rheumatoid Arthritis | 2010 | 240˙709.00 | 240˙709.00 |
7 | MOREFV Molecular regulation of blood coagulation factor V: from snakes to humans | 2010 | 100˙000.00 | 100˙000.00 |
8 | VACCINATION TO CMV Dissection of T cell cosignaling and development of vaccination strategies to cytomegalovirus | 2010 | 217˙099.00 | 217˙099.00 |
9 | IDEAL Integrated research on DEvelopmental determinants of Aging and Longevity | 2011 | 15˙935˙888.00 | 11˙986˙951.00 |
10 | UNDERNEATH MIGRAINE Underneath the attack: cortical network function in migraine | 2011 | 100˙000.00 | 100˙000.00 |
11 | HIGHGLYCAN Methods for high-throughput (HTP) analysis of protein glycosylation | 2011 | 7˙799˙296.00 | 5˙998˙972.00 |
12 | HPSCLQT Human pluripotent stem cells for modeling and correcting long-QT syndrome | 2012 | 183˙805.00 | 183˙805.00 |
13 | ILLUMINATING NERVES Hybrid imaging agents for the illumination of peripheral nerve structures | 2012 | 1˙498˙800.00 | 1˙498˙800.00 |
14 | ENIGMAS Explicitly Normalized ImaGing MAss Spectrometry | 2012 | 183˙805.00 | 183˙805.00 |
15 | MIMOMICS Methods for Integrated analysis of Multiple Omics datasets | 2012 | 7˙883˙081.00 | 5˙993˙308.00 |
16 | STELLAR Stem-cell based therapy for kidney repair | 2012 | 9˙642˙381.00 | 5˙998˙050.00 |
17 | VACTRAIN Training network for next generation vaccinologists | 2012 | 3˙060˙467.00 | 3˙060˙467.00 |
18 | TIMCC Tumor Infiltrating Myeloid Cell Compartment | 2012 | 3˙756˙469.00 | 3˙756˙469.00 |
19 | TRANCYST Translational research (training) in Polycystic Kidney Disease | 2012 | 2˙763˙732.00 | 2˙763˙732.00 |
20 | EUROSTAM A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches | 2012 | 3˙737˙167.00 | 2˙623˙500.00 |
21 | DECODINGSUMO Cracking the SUMO Signalling Code | 2013 | 1˙517˙698.00 | 1˙517˙698.00 |
22 | RECYCLING PARKINSON Synaptic vesicle recycling and Parkinson’s disease | 2013 | 100˙000.00 | 100˙000.00 |
23 | SITH Proteomic segmentation of intratumour heterogeneity for identifying clinically relevant tumour subpopulations in gastrointestinal cancers | 2013 | 175˙974.00 | 175˙974.00 |
24 | REACH bioREACtor for stem cell tHerapy | 2013 | 6˙790˙994.00 | 5˙012˙127.00 |
25 | CARDIMMUN A new therapeutic antibody with a personalised medicine approach in cardiovascular disease | 2013 | 7˙785˙840.00 | 5˙995˙080.00 |
26 | 3GB-TEST Introducing diagnostic applications of ‘3Gb-testing’ in human genetics | 2013 | 553˙889.00 | 499˙668.00 |
27 | STEMCARDIOVASC Human Pluripotent Stem Cells: the new heart patient? | 2013 | 2˙500˙000.00 | 2˙500˙000.00 |
28 | SURVIVE Integrating cancer detection and SURgery Via molecular Imaging | 2013 | 2˙487˙600.00 | 2˙487˙600.00 |
29 | EUROHEADPAIN Mechanisms and Treatment of Migraine and its Chronification | 2014 | 8˙113˙758.00 | 5˙996˙726.00 |
30 | CHROMATINREPAIRCODE CHROMATIN-REPAIR-CODE: Hacking the chromatin code for DNA repair | 2014 | 1˙999˙575.00 | 1˙999˙575.00 |
31 | IMAGE-GUIDED SURGERY Preclinical Protocols For Image-Guided Surgery | 2014 | 243˙847.00 | 243˙847.00 |
32 | IRESOLUTION The role of Western lifestyle factors in smoke-induced inflammation in chronic obstructive pulmonary disease | 2014 | 175˙974.00 | 175˙974.00 |
33 | DENDRITIC CELLS Identification and targeting of metabolic pathways in dendritic cells that regulate their immune polarizing function | 2015 | 75˙000.00 | 75˙000.00 |
L'Ente academisch ziekenhuis leiden partecipato anche in questi progetti.